1. Home
  2. CBT vs XENE Comparison

CBT vs XENE Comparison

Compare CBT & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabot Corporation

CBT

Cabot Corporation

HOLD

Current Price

$93.40

Market Cap

4.7B

Sector

Industrials

ML Signal

HOLD

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$59.74

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBT
XENE
Founded
2019
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.2B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
CBT
XENE
Price
$93.40
$59.74
Analyst Decision
Hold
Strong Buy
Analyst Count
3
11
Target Price
$70.00
$68.55
AVG Volume (30 Days)
542.0K
1.4M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
2.64
N/A
Revenue
$3,713,000,000.00
$311,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.94
$2,496.48
P/E Ratio
$35.26
N/A
Revenue Growth
N/A
N/A
52 Week Low
$58.33
$30.00
52 Week High
$93.71
$62.91

Technical Indicators

Market Signals
Indicator
CBT
XENE
Relative Strength Index (RSI) 64.77 67.84
Support Level $71.30 $52.40
Resistance Level N/A $59.43
Average True Range (ATR) 2.66 1.71
MACD 0.45 0.70
Stochastic Oscillator 90.14 94.90

Price Performance

Historical Comparison
CBT
XENE

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: